Search results
Results From The WOW.Com Content Network
In 2014, Dr Lal PathLabs acquired the APL Clinical Institute of Clinical Laboratory & Research Private Limited. [6] Dr Lal PathLabs launched its IPO in 2015. [7] The company got listed on BSE and NSE on 23 December 2015. [8] In 2021, Dr Lal PathLabs acquired Suburban Diagnostics for an enterprise value of ₹ 925 crore in an all-cash deal. [9]
The economy of Malaysia (GDP PPP) in 2014 was $746.821 billion, the third largest in ASEAN behind Indonesia and Thailand and the 28th largest in the world. [6] [needs update] For further information on the types of business entities in this country and their abbreviations, see "Business entities in Malaysia".
Established in 2001 and headquartered in Kuala Lumpur, Malaysia's largest cord blood banking operator StemLife, is the first stem cell banking and therapeutics company in Malaysia. Stemlife became a majority-owned subsidiary of Cordlife Group Limited in December 2015.
Limited by Guarantee (Ltd./Gte.): a company limited by guarantee (non-profit company) Unlimited (ULtd.): A company with a share capital, similar to its limited company (Ltd., or PLC.) counterparts, but where the liability of the members or shareholders is not limited; Limited Liability Partnership (LLP): Only allowed in the state of Lagos, Nigeria.
Clinical pathology is a medical specialty that is concerned with the diagnosis of disease based on the laboratory analysis of bodily fluids, such as blood, urine, and tissue homogenates or extracts using the tools of chemistry, microbiology, hematology, molecular pathology, and Immunohaematology.
The company’s headquarters, Menara KPJ, is located in Kuala Lumpur. KPJ Healthcare is listed on the Main Market of Bursa Malaysia, with a market capitalisation of RM7.9 billion as of 26 July 2024. The company’s primary focus is the management of a comprehensive network of specialist hospitals.
Parkway Pantai, Ltd. is a medical company based in Singapore and is Southeast Asia's largest private healthcare provider, and one of the largest in Asia. It is a wholly owned subsidiary of Kuala Lumpur -based IHH Healthcare , whose largest shareholder is Malaysian state investment agency Khazanah Nasional . [ 1 ]
With five manufacturing plants, including Indonesia plant, Pharmaniaga is capable of producing products in various forms; from oral solids, liquids and creams to small volume injectables. Its product portfolio encompasses a diverse segment of therapeutic areas such as cardiovascular, diabetes, anti-infectives, pain management, and respiratory ...